[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592498":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":26,"responsibleParty":43,"collaborators":10,"id":45,"slug":10,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":10,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Ente Ospedaliero Ospedali Galliera","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"ARM 1",null,"Patients with melanoma diagnosis aged between 18 and 39 years.",[13],{"name":14,"affiliation":5,"role":15},"Sanja Javor","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Sanja Javor, MD","CONTACT","+390105634271","sanja.javor@galliera.it",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":25},"Davide Corradengo","+39010.563.4580","davide.corradengo@galliera.it",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"E.O. Ospedali Galliera","RECRUITING","Genoa","Liguria","16128","Italy",{"type":35,"coordinates":36},"Point",[37,38],8.94439,44.40478,{"lat":38,"lon":37},[41],{"name":18,"role":19,"phone":42,"phoneExt":10,"email":21},"+390105634278",{"type":15,"investigatorFullName":14,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Medical doctor","100592498",false,"NCT06994208","Characteristics of Adult Patients With Melanoma Diagnosis \u003C40 Years Age.","Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis \u003C40 Years Age. A Prospective, Monocentric Observational Study","MELA_2025","Inclusion Criteria:\n\n1. written informed consent\n2. age \\> 18 years and \\\u003C 40 years\n3. diagnosis of cutaneous melanoma even non-primary\n\nExclusion Criteria:\n\n\\-","ALL","18 Years","39 Years",{"count":56,"type":57},25,"ESTIMATED","1 Year","OBSERVATIONAL","The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.\n\nSecondary objectives are the following:\n\n* To identify risk factors associated with melanoma in young people.\n* To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years.\n* To analyse the relationship between the clinical and histopathological features of melanoma in young people.\n* To identify the mutational status of B-RAF in the sample of patients analysed.",[62],"Melanoma of Skin","2025-12-18",{"date":65,"type":66},"2025-12-19","ACTUAL",{"date":68,"type":66},"2025-12-02",{"date":70,"type":57},"2028-08-31",{"name":5,"class":6},1]